Navigation Links
ThromboGenics is Shortlisted for "Biotech Company of the Year" and "Licensing Deal of the Year" at Scrip Awards 2009
Date:9/11/2009

th year running and the awards ceremony will take place on November 18, 2009 in London.

Patrik De Haes, CEO of ThromboGenics, commented, "We are very pleased to have been shortlisted for both the Biotech Company of the Year and Licensing Deal of the Year awards at this prestigious awards event. The nominations are a testament to the significant achievements and progress ThromboGenics has made over the last year. The Company is now in the best position to achieve its aim of becoming a profitable, integrated Company focused on cutting edge ophthalmic medicines. We are very proud to be nominated amongst some of the most successful companies in the industry, and look forward to the results in November."

About ThromboGenics

ThromboGenics is a biotechnology company focused on the discovery and development of innovative medicines for the treatment of eye disease, vascular disease and cancer. The Company's lead product microplasmin is in Phase III clinical development for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal indications and as a potential therapy for stroke. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioInvent International; these include TB-402 (Anti-Factor VIII), a long acting anti-coagulant, and TB-403 (anti-PlGF) for cancer.

ThromboGenics has built strong links with the University of Leuven and the Flanders Institute for Biotechnology (VIB) and has exclusive rights to certain therapeutics developed at these institutions. ThromboGenics is headquartered in Leuven, Belgium. The Company is listed on Eurolist by Euronext Brussels under the symbol THR. More information is available at http://www.thrombogenics.com.

About Scrip World Pharmaceutical
'/>"/>

SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
2. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
3. ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402
4. ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
5. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
6. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
7. ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
8. ThromboGenics Announces 2007 Full Year Results
9. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
10. ThromboGenics N.V. - Business Update
11. ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014 Silicon-valley Electronic Data Capture ... Digitaliza TXT , the latest addition to Clinovo’s CRO ... Research Organization (CRO) Program, Clinovo further expands its global ... of ClinCapture training, we are now able to build ... Pulido. “We can also rely on Clinovo to fully ...
(Date:9/18/2014)... Mexico City, MX (PRWEB) September 18, 2014 ... event in Mexico City, MX. ASEA is the manufacturer ... drink and the skin care product, RENU28. , ... Samuelson, Regional Vice President Duvan Botero, and ASEA Field ... L. Samuelson holds a PhD in Atomic/Medical Physics from ...
(Date:9/17/2014)... Nev. , Sept. 17, 2014  PDL BioPharma, Inc. ... its independent registered accounting firm, Ernst & Young LLP ("EY") ... was confirmed in a letter delivered to the Company on ... on September 16, 2014.  PDL has issued ... "We have received a number of inquiries on the reason ...
(Date:9/17/2014)... , Sept. 17, 2014 The global consumption ... by 2019. Squalene is a natural skin-identical chemical that finds ... personal care, food supplements, pharmaceuticals, and in other applications like ... squalene market has a few major players and is regionally ... Kishimoto Special Liver Oil Co. Ltd. ( Japan ...
Breaking Biology Technology:Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture to Latin America 2Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture to Latin America 3Announcing the ASEA Mexico Grand Opening Tour Beginning September 18th 2PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 2PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 3Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3
... - Sales Up 15% - Non-GAAP Operating Earnings Up ... - Non-GAAP Diluted EPS Up 29%, ... 29 Varian, Inc.,(NasdaqGS: VARI) today reported fourth fiscal quarter ... revenues of $245.6,million in the fourth quarter of fiscal year ...
... BEDFORD, Mass., Oct. 29 Aware, Inc. (Nasdaq:,AWRE), a ... that its Board of Directors has approved an extension ... repurchase from,time to time at management,s discretion up to ... in the open market or in private until December,31, ...
... SEATTLE, Oct. 29 Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ... an overview of the company at two upcoming industry ... 10th Annual Healthcare Conference at the,New York Palace Hotel, ... financial officer and senior vice president, is scheduled to ...
Cached Biology Technology:Varian, Inc. Reports Strong Fourth Quarter 2008 Results 2Varian, Inc. Reports Strong Fourth Quarter 2008 Results 3Varian, Inc. Reports Strong Fourth Quarter 2008 Results 4Varian, Inc. Reports Strong Fourth Quarter 2008 Results 5Varian, Inc. Reports Strong Fourth Quarter 2008 Results 6Varian, Inc. Reports Strong Fourth Quarter 2008 Results 7Varian, Inc. Reports Strong Fourth Quarter 2008 Results 8Varian, Inc. Reports Strong Fourth Quarter 2008 Results 9Varian, Inc. Reports Strong Fourth Quarter 2008 Results 10Varian, Inc. Reports Strong Fourth Quarter 2008 Results 11Varian, Inc. Reports Strong Fourth Quarter 2008 Results 12Varian, Inc. Reports Strong Fourth Quarter 2008 Results 13Varian, Inc. Reports Strong Fourth Quarter 2008 Results 14Varian, Inc. Reports Strong Fourth Quarter 2008 Results 15Varian, Inc. Reports Strong Fourth Quarter 2008 Results 16Varian, Inc. Reports Strong Fourth Quarter 2008 Results 17Varian, Inc. Reports Strong Fourth Quarter 2008 Results 18Varian, Inc. Reports Strong Fourth Quarter 2008 Results 19Varian, Inc. Reports Strong Fourth Quarter 2008 Results 20Varian, Inc. Reports Strong Fourth Quarter 2008 Results 21Varian, Inc. Reports Strong Fourth Quarter 2008 Results 22Varian, Inc. Reports Strong Fourth Quarter 2008 Results 23Varian, Inc. Reports Strong Fourth Quarter 2008 Results 24Varian, Inc. Reports Strong Fourth Quarter 2008 Results 25Varian, Inc. Reports Strong Fourth Quarter 2008 Results 26Varian, Inc. Reports Strong Fourth Quarter 2008 Results 27Aware, Inc. Announces Extension of Stock Repurchase Plan 2Trubion Announces Presentations at Upcoming Investor Conferences 2
(Date:9/18/2014)... Americans across racial and ethnic groups describe losing ... their day-to-day life, more so than other conditions ... (57% of African-Americans, 49% of non-Hispanic whites, 43% ... which disease or ailment is the worst that ... African-Americans followed by AIDS/HIV. Hispanics and Asians ...
(Date:9/18/2014)... Elsevier, a world-leading provider of scientific, technical ... Australasian Research Management Society (ARMS), recognized the academic ... 5th Scopus Young Researcher of the Year Awards. ... the National Convention Centre and in conjunction with ... guests representing Australia,s and New Zealand,s scientific community. ...
(Date:9/18/2014)... their entire lives nestling in the protective tentacles of ... they sometimes travel hundreds of kilometres across the open ... fish has been predicted, this is the first time ... populations has been observed. , Dr Steve Simpson, Senior ... University of Exeter, and colleagues from the Australian Research ...
Breaking Biology News(10 mins):Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2Expedition finds Nemo can travel great distances to connect populations 2Expedition finds Nemo can travel great distances to connect populations 3
... virus in new clothes enables it to hunt down metastasized ... study in the Feb. 13 online edition of Nature Medicine. ... the virus in order to track its journey from the ... the past 20 years, gene therapy has been hampered by ...
... ice age was beginning to wane, often are attributed in part ... led by University of Washington researchers, an ice core of 1,000 ... a key section of the West Antarctic Ice Sheet probably never ... means it couldn't have contributed as much to the higher sea ...
... Glia appear essential for 'hair cells',responsible for hearing ... as glia may be essential for the normal ... according to new,University of Utah research. The study ... Neuron and is co-authored by scientists at the ...
Cached Biology News:UCLA scientists transform HIV into cancer-seeking missile 2Ice core 'dipstick' indicates West Antarctic ice has thinned less than believed 2Ice core 'dipstick' indicates West Antarctic ice has thinned less than believed 3Harmful Bacterium Commonly Found in Poultry May Survive Refrigeration and Frozen Storage Combined 2
EDG-6 Lysate Source: Cell Lysate Application: Western Blotting Control Form: IgG...
3T3 cells (RSV-transformed) Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Madin-Darby bovine kidney (MDBK) cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
A431 cells stimulated with EGF Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Biology Products: